TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -4 | -12 | 1 | -16 | 73 | 3 | 8 |
| S | %wins | 100 | 100 | 50 | 100 | 50 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/15 18:22 | 1/8/15 | RNN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jeong Tae Heum | MD | O | CFO | S.dm | -289 | 0.9113 | 1 | -317 | -39 | 505 | D | 171 | 31 | 14 | 23 | 33 | 28 | 30 | 21 | -8 | -19 | -15 | -15 | -36 | -61 |
9/11/13 18:01 | 9/9/13 | RNN | Rexahn Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jeong Tae Heum | MD | O | CFO | S.d | -32 | 0.4565 | 1 | -71 | -12 | 505 | D | -57 | -6 | 33 | -12 | -15 | -2 | 19 | 7 | 0 | -4 | 16 | -16 | 182 | 66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |